GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sakar Healthcare SAKAR.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,028.65

+5.44%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹2.52bn

FY2017FY2026

Net income

₹304.8m

FY2017FY2026

Free cash flow

₹110.2m

FY2017FY2026

Shareholders' equity

₹3.24bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹2.52bn₹1.78bn₹1.54bn₹1.33bn₹1.28bn₹947.4m₹829.8m₹682.5m₹530.8m₹441.7m
Gross profit₹661.8m₹427.9m₹699.6m₹598.1m₹534.1m₹432.5m₹391.8m₹325.6m₹247.9m₹218.9m
Research and development₹1.5m₹2.2m₹5.5m₹7.2m₹1.1m₹120,900₹478,000₹3.4m₹330,137—
Operating income₹453.2m₹288.0m₹495.5m₹184.6m₹388.9m₹149.7m₹136.0m₹131.4m₹82.2m₹99.4m
Net income₹304.8m₹175.0m₹116.7m₹127.6m₹152.4m₹106.8m₹96.2m₹70.1m₹38.1m₹33.8m
Diluted earnings per share13.707.875.365.878.206.626.424.703.123.09

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹4.81bn₹4.15bn₹3.89bn₹3.36bn₹2.68bn₹1.78bn₹1.15bn₹986.8m₹811.0m₹705.9m
Cash and short-term investments₹2.6m₹3.1m₹4.7m₹35.2m₹71.4m₹824,649₹3.0m₹3.7m₹3.6m₹4.5m
Total liabilities₹1.57bn₹1.30bn₹1.26bn₹1.63bn₹1.40bn₹793.4m₹338.0m₹269.8m₹296.1m₹350.8m
Debt₹553.0m₹749.5m₹793.5m₹1.19bn₹928.6m₹426.0m₹167.0m₹117.5m₹145.5m₹244.7m
Shareholders' equity₹3.24bn₹2.85bn₹2.62bn₹1.73bn₹1.27bn₹984.5m₹813.2m₹717.0m₹514.9m₹355.0m
Shares outstanding22m22m22m22m19m16m15m15m12m11m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹393.7m₹340.3m₹244.7m₹353.1m₹357.0m₹145.8m₹101.2m₹191.0m₹52.6m₹195
Capital spending−₹283.5m−₹322.8m−₹595.6m−₹822.0m−₹975.3m−₹355.5m−₹136.7m−₹249.1m−₹88.1m−₹1,507
Free cash flow₹110.2m₹17.5m−₹350.9m−₹468.8m−₹618.3m−₹209.7m−₹35.4m−₹58.0m−₹35.4m−₹1,312

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹729.7m₹711.0m₹703.4m₹575.6m₹527.4m₹502.4m₹434.2m₹427.8m
Gross profit₹203.9m₹238.4m₹185.5m₹131.3m₹237.8m₹142.1m₹207.8m₹93.1m
Operating income₹147.1m₹203.0m₹122.2m₹56.7m₹71.3m₹104.3m₹65.3m₹63.8m
Net income₹102.8m₹110.2m₹102.5m₹45.4m₹46.7m₹57.6m₹45.3m₹48.0m
Diluted earnings per share4.624.954.612.042.102.592.082.20
Cash from operations———₹305.0m—₹340.0m—₹210.0m
Capital spending———−₹273.0m—−₹322.0m—−₹130.0m
Free cash flow———₹32.0m—₹18.0m—₹80.0m
Total assets—₹4.81bn—₹4.49bn—₹4.15bn—₹4.04bn
Cash and short-term investments₹2.6m₹2.6m₹2.2m₹2.2m₹3.1m₹3.1m₹5.3m₹5.3m
Debt—₹553.0m—₹718.6m—₹749.5m—₹838.7m
Shareholders' equity₹3.24bn₹3.24bn₹3.03bn₹3.03bn₹2.85bn₹2.85bn₹2.69bn₹2.69bn

Financial ratios

Data as of 5 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin26.3%24.1%45.4%44.9%41.7%45.6%
Operating margin18.0%16.2%32.1%13.8%30.3%15.8%
Net margin12.1%9.9%7.6%9.6%11.9%11.3%
Return on equity9.4%6.1%4.4%7.4%12.0%10.9%
Return on assets6.3%4.2%3.0%3.8%5.7%6.0%
Free cash flow yield3.0%3.0%3.8%5.4%7.1%3.1%
Revenue growth41.8%15.2%15.6%4.0%35.3%14.2%
Earnings growth74.2%50.0%-8.5%-16.3%42.7%11.0%
Current ratio1.28x1.40x1.21x1.03x1.07x1.01x
Debt to equity0.17x0.26x0.30x0.69x0.73x0.43x
Equity ratio67.5%68.7%67.5%51.5%47.6%55.4%
Interest coverage5.77x3.37x6.53x3.10x13.42x6.03x
R&D as a share of sales0.1%0.1%0.4%0.5%0.1%0.0%
Buybacks as a share of market value0.0%-2.1%-0.2%-17.1%-15.1%-7.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.6%21.6%19.8%
Operating income34.9%24.8%31.8%
Net income33.7%23.3%30.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin25.4%33.3%35.7%38.5%
Operating margin17.3%19.8%20.9%19.8%
Net margin11.2%10.1%10.5%10.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings74.252.055.468.227.324.615.314.319.120.1
Price to sales9.05.14.26.53.32.81.81.51.41.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.